Phenotypic clustering in MPZ mutations

Michael E Shy1, Agnes Jáni, Karen Krajewski

  • 1Department of Neurology, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, USA. m.shy@wayne.edu

Insights

Myelin protein zero (MPZ) mutations cause inherited neuropathies like CMT1B. Disruptions in MPZ structure lead to early-onset severe disease, while subtle changes cause later-onset neuropathy, impacting myelin compaction and cell interactions.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Myelin protein zero (MPZ) is crucial for myelin compaction and adhesion in the nervous system.
  • Mutations in MPZ cause inherited demyelinating neuropathies, including Charcot-Marie-Tooth disease type 1B (CMT1B).
  • Clinical presentations of MPZ-related neuropathies vary, ranging from early-onset severe forms to later-onset milder phenotypes.

Purpose of the Study:

  • To correlate specific MPZ mutations with their resulting clinical phenotypes in patients.
  • To understand the molecular mechanisms underlying the diverse presentations of MPZ-related neuropathies.

Main Methods:

  • Genotypic analysis of 13 patients from 12 families with eight distinct MPZ mutations.
  • Re-analysis of clinical data from 64 published CMT1B cases.
  • Correlation of identified MPZ mutations with patient phenotypes.

Main Results:

  • Most patients presented with either early-onset (prior to walking) or late-onset (around age 40) neuropathy, with 'classical' CMT phenotypes being less common.
  • Mutations affecting the extracellular domain (charged amino acid addition, cysteine alteration) or cytoplasmic domain (truncation, conserved amino acid alteration) correlated with severe early-onset neuropathy.
  • Subtle alterations in myelin structure due to specific mutations likely lead to late-onset neuropathy by disrupting Schwann cell-axonal interactions.

Conclusions:

  • MPZ mutations significantly disrupting tertiary structure cause severe early-onset neuropathies by impairing myelin adhesion and compaction.
  • More subtle MPZ alterations lead to late-onset neuropathies, likely through disrupted Schwann cell-axonal interactions.
  • Genotype-phenotype correlations in MPZ mutations provide insights into the molecular basis of inherited demyelinating neuropathies.